- Home
- AXSM vs HHH Comparison
AXSM vs HHH Comparison
Compare AXSM & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | HHH |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 3.7B |
| IPO Year | 2015 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AXSM | HHH |
|---|---|---|
| Price | $162.45 | $63.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 2 |
| Target Price | ★ $210.65 | $90.00 |
| AVG Volume (30 Days) | 507.0K | ★ 527.3K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ 2.21 |
| Revenue | N/A | ★ $1,474,892,000.00 |
| Revenue This Year | $58.18 | $14.04 |
| Revenue Next Year | $55.45 | N/A |
| P/E Ratio | ★ N/A | $28.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $86.99 | $61.01 |
| 52 Week High | $191.50 | $91.07 |
Technical Indicators
Market Signals| Indicator | AXSM | HHH |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 35.16 |
| Support Level | $153.37 | N/A |
| Resistance Level | $169.11 | $71.26 |
| Average True Range (ATR) | 4.13 | 1.62 |
| MACD | 0.88 | 0.42 |
| Stochastic Oscillator | 68.34 | 40.65 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.